Factors influencing the time to administration of thrombolytic therapy with recombinant tissue plasminogen activator (data from the national registry of myocardial infarction)
- 15 September 1995
- journal article
- clinical trial
- Published by Elsevier BV in The American Journal of Cardiology
- Vol. 76 (8), 548-552
- https://doi.org/10.1016/s0002-9149(99)80152-0
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Treatment of myocardial infarction in the United States (1990 to 1993). Observations from the National Registry of Myocardial Infarction.Circulation, 1994
- Prehospital-Initiated vs Hospital-Initiated Thrombolytic TherapyJAMA, 1993
- Prehospital Thrombolytic Therapy in Patients with Suspected Acute Myocardial InfarctionThe New England Journal of Medicine, 1993
- Hospital delays and problems with thrombolytic administration in patients receiving thrombolytic therapy: A multicenter prospective assessmentAnnals of Emergency Medicine, 1992
- Feasibility, safety, and efficacy of domiciliary thrombolysis by general practitioners: Grampian region early anistreplase trial. GREAT Group.BMJ, 1992
- Effect of "fast track" admission for acute myocardial infarction on delay to thrombolysis.BMJ, 1992
- Reducing delay in the emergency room in administration of thrombolytic therapy for myocardial infarction associated with ST elevationThe American Journal of Cardiology, 1991
- Time delays in the diagnosis and treatment of acute myocardial infarction: A tale of eight cities Report from the Pre-hospital Study Group and the Cincinnati Heart ProjectAmerican Heart Journal, 1990
- Delay between onset of chest pain and seeking medical care: The effect of public educationAnnals of Emergency Medicine, 1989
- Effect of a media campaign on delay times and ambulance use in suspected acute myocardial infarctionThe American Journal of Cardiology, 1989